View full contract details ↓ View on SAM.gov ↗
This is a combined synopsis/solicitation for commercial items prepared in accordance with the Revolutionary FAR Overhaul (RFO) in Federal Acquisition Regulation (FAR) subpart 12.202, �Streamlined Procedures for Evaluation and Solicitation for Commercial Products and Commercial Services,� as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation document will not be issued. This solicitation RFQ- 36C25026Q1013 is issued as a request for quote (RFQ). This solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2026-01, effective 03/13/2026.
This is a firm fixed price, Small Business Set-Aside solicitation. The North American Industry Classification System (NAICS) number is 334510. NOTE: This solicitation is for one Transcranial Magnetic Stimulation System that is FDA-cleared for Major Depressive Disorder (MDD) and obsessive-compulsive disorder (OCD). All interested companies shall provide quotations for the requirements listed below.
Materials and parts will be delivered to: Richard L. Roudebush VA Medical Center, 1481 W. 10th St., Indianapolis, IN 46202, FOB destination. Minimum Requirements The required TMS device must have the following salient characteristics, specific to the clinical needs and operation at our VAMC: - Delivers a series of pulsed magnetic stimuli to targeted regions of the brain, following predefined treatment protocols. - Non-invasive procedure�requires no anesthesia and does not disrupt normal cognitive functions. - Flat purchase model: No pay-per-use fees; acquisition includes all treatment protocols. - Upgradeable treatment protocols: Device must support future p…
XL Eagle · Certified Small Business · CAGE 11R42 · info@xleagle.com · (832) 380-5845